GlassScriptPhysician profile
Laura L Dooley
NPI 1780983130
$909.84
in general payments reported to CMS, 2019-2025
20 companies · $529 in 2025
The $529 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $31.50 · 2022: $127 · 2023: $41.36 · 2024: $181 · 2025: $529.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $708 · Education: $42.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $708.45 |
| Education | $42.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $167.64 | 2022-2025 | Gvoke Hypopen |
| Mannkind Corporation | $84.96 | 2025 | |
| Novo Nordisk INC | $77.99 | 2021-2025 | Ozempic, Rybelsus, Saxenda |
| Insulet Corporation | $75.01 | 2025 | Omnipod |
| Sequel Med Tech, LLC | $58.10 | 2025 | Twiist |
| Sanofi-Aventis U.S. LLC | $57.63 | 2022-2025 | |
| Dexcom, INC. | $57.31 | 2022-2024 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $50.34 | 2025 | Mounjaro, Zepbound |
| Beta Bionics, INC. | $41.89 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Madrigal Pharmaceuticals | $37.38 | 2025 | Rezdiffra |
| Tandem Diabetes Care, INC. | $26.76 | 2021-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Corcept Therapeutics | $25.43 | 2025 | Korlym |
| Antares Pharma, INC. | $24.29 | 2025 | Xyosted |
| Ascensia Diabetes Care US INC. | $20.39 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.11 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $18.91 | 2024 | |
| Sandoz INC. | $17.31 | 2025 | Jubbonti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.75 | 2024 | Jardiance |
| Abbott Laboratories | $16.53 | 2024 | Freestyle Libre 3 |
| Medtronic, INC. | $16.11 | 2025 | Minimed 780g |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Dooley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.